Drug company chief urges faster introduction of new vaccines in poor nationsBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7557.11-a (Published 29 June 2006) Cite this as: BMJ 2006;333:11
- John Zarocostas
The head of a leading drug company has urged the world's health community to speed up the introduction of new life saving vaccines in poor countries and avoid the customary lengthy delays.
“Many new vaccines are becoming a reality against rotavirus, pneumocccal disease, and cervical cancer,” the president of GlaxoSmithKline Biologicals, Jean Stéphenne, said. “These vaccines are there, so it's important to introduce them today in developing countries and not 20 years later.”
He said that with the exception of the rotavirus vaccine, which was introduced in Latin America and Europe …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial